Insider buying last 90 days
$75Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Jun 29 | William R Shepard Director | Purchase | $75K |
From Form 4 filings, dated to when each was filed.
NASDAQ: CME
CME (CME) Stock Analysis & Forecast
$276.01+4.86 (+1.8%)
Close on Sep 18, 2026. Page updated Sep 19, 9:18 pm ET.
Gekko Brief
AI summaryCME closes at $276.01, up 1.8%, sitting between its 50-day average of $266.27 and 200-day average of $278.71. The GekkoIndex reads 56.7, placing the stock in the Neutral zone, while Gekko Fair Value stands at $273.20, putting price about 1% above that mark. Over the past month the stock is up 3.4%, and over three months up 12%, though it remains down 11.2% over six months and up 5.2% over the past year, with a 52-week range of $218.31 to $329.16.
This week's coverage centers on CME's product expansion and its position as the dominant derivatives marketplace. The company launched Liquid Leveraged Loan Index futures on September 14, its 24/7 silver futures drew $15 million in notional trading over their debut weekend with 2,387 contracts, and Webull began offering CME Nano Futures to retail customers. Commentary also notes CME trades at an EV/EBITDA of 21.5x versus a peer average of 16.2x, and cites a 62% net margin, alongside a director's sale of 500 shares for $140,055 on September 14.
CME's next earnings report is set for 21 October 2026, before the open, 31 days out and beyond a typical 20-day hold. In the last quarter, EPS of $2.99 beat the $2.91 estimate, with a 7.1% reaction, and the company has beaten estimates in 6 of the last 8 quarters. Over the last 90 days there has been 1 open-market insider purchase totaling $74,885, alongside 2 billionaire holders. Analyst views are split, with 4 buy, 5 hold, and 3 sell ratings among 12 firms, and a consensus target of $283.60. Seasonally, the next 20 trading days have averaged a 3.5% gain over 5 years, rising in 4 of them.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Price vs fair value
Close $276.01200-day averageGekko Fair Value $273.20
Key stats
- Market cap
- $99.25B
- P/E ratio
- 23.1
- Forward P/E
- 22.1
- EPS, TTM
- $11.74
- Revenue, TTM
- $6.76B
- Profit margin
- 63.4%
- Dividend yield
- 1.87%
- Beta
- 0.28
- Volume
- 3.28M avg 1.85M
- 1-year return
- +5.2%
- Typical daily move
- ±2%
- Typical 20-day move
- ±3.5%
- 50-day average
- $266.27
- 200-day average
- $278.71
- Next earnings
- Oct 21 before open
- Shares outstanding
- 359.6M
CME swing-trade checklist
CME scores 3 supportive, 3 mixed and 0 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive3 mixed0 headwinds
- Trendmixed
Averages disagree
Close $276.01 sits between the 50-day ($266.27) and 200-day ($278.71) averages, or the averages disagree.
See the chart - GekkoIndexmixed
56.7, Neutral
Reading 56.7 is in the Neutral zone.
See the GekkoIndex - Fair valuemixed
1.0% above
Price is within 5% of Gekko Fair Value (1% above).
See fair value - Smart moneysupportive
Leans bullish
Last 90 days: 1 open-market insider purchase.
See smart money - Earnings risksupportive
Reports in 31 days
Next report Oct 21, 2026, 31 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+3.5% on average
From this point in the calendar, the next 20 trading days averaged +3.5% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
CME stock chart and price history
CME closed at $276.01 on Sep 18, 2026, +5.2% over the past year, inside a 52-week range of $218.31 to $329.16.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +3.4%
- 3 months
- +12.0%
- 6 months
- −11.2%
- 1 year
- +5.2%
The full CME chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CME in Gekko
Follow CME through every session
Put CME on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track CME in GekkoFree for 7 days. No credit card required.
About CME
CME runs global marketplaces where participants trade futures contracts and options tied to those futures. The contracts it lists reference interest rates, stock indices, currency pairs, farm goods, energy, metals and fixed-income instruments. It has built a name for itself through these exchange venues used across markets worldwide.
On top of hosting trades, CME confirms, settles and stands behind futures, options and cleared swap transactions through its clearinghouse operations, and it supports the processing of trades and management of related risk. The company also sells data products, delivering both live feeds and historical records to subscribers. Its customer base ranges from professional and institutional traders to banks, corporate treasuries, manufacturers, commodity producers, governments and central banks.
The company got its start in Chicago, Illinois, back in 1898, originally operating as Chicago Mercantile Exchange Holdings Inc. before taking on its current name in July 2007. CME shares are listed on the NASDAQ under the ticker CME.
- Listed
- NASDAQ
- Sector
- Finance
- Industry
- Investment banks/Brokers
- Website
- cmegroup.com
CME GekkoIndex: the smart money zone
CME’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.7, in the Neutral zone, up 0.6 points over five sessions.
56.7Neutral
Up 0.6 points over five sessions.
Reading for Sep 18, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 9 | Too few readings yet | |||
| Accumulation | 189 | +0.3% | +0.9% | ||
| Neutral (current zone) | 413 | +0.3% | +1.2% | ||
| Distribution | 46 | −0.3% | +0.9% | ||
| Selling | 5 | Too few readings yet | |||
Average CME share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the CME price, zone by zone.Track CME in Gekko
Is CME stock overvalued? Gekko Fair Value
CME trades 1.0% above Gekko Fair Value of $273.20, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what CME shares are worth, recalculated every trading day.
$273.20
Gekko Fair Value, Sep 19, 2026
1.0% above fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open CME in Gekko
CME insider and Congress trading
Insiders filed 1 open-market purchase in CME worth $75K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in CME were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for CME, plotted on the chart in Gekko.Open CME in Gekko
Buybacks
CME has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $698.2M
- As a share of market cap
- 0.70%
- Trailing four quarters
- $1.52B
From company filings.
Hedge funds and billionaires quarter ended Jun 30
2of the funds Gekko tracks hold CME.
0added2opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
CME earnings: next date and track record
CME reports on Oct 21, 2026, before the open (31 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Oct 21, 2026
Expected before the open, 31 days away
- EPS estimate
- $2.96
- Revenue estimate
- $1.69B
6 of 8reports beat the EPS estimate
±2%average move across the report
7 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 22, 2026 AI summary
- What they said
- CME Group reported a strong Q2 2026 with record second-quarter revenue of over $1.7 billion (up 1% YoY) and robust first-half performance (volume +10% YoY, open interest +8%). Management highlighted market data strength (market data revenue +20% to $238 million), high adjusted operating margin (69.5%), and continued capital efficiencies (saving customers ~$95 billion in margin per day). The company emphasized institutional dominance (94% of volume from institutional customers) while addressing competitive and regulatory developments in retail-focused perpetual futures. Management discussed multiple product initiatives — 24/7 crypto and metals trading, launch of Single Stock futures (financially settled), Compute Futures (NVIDIA H100 GPU rental-cost benchmark), Treasury Link (atomic execution between BrokerTec and futures expected Q4 2026), and expansion of prediction markets — and noted strong early interest and distribution partnerships. The call included discussion of regulatory and litigation matters (CFTC stay on a 24/7 crude filing and ongoing litigation), and management reiterated confidence in CME’s role as a neutral, institutional-focused market infrastructure provider.
- Guidance
- Operational/timing guidance provided: July-to-date Q3 volumes tracking ~18% ahead of last year; Treasury Link expected launch in Q4 2026; Single Stock futures scheduled to list next Monday (per call timing); 24/7 crypto trading and certain metals products are live or launching imminently; no formal financial guidance (no EBITDA/earnings/revenue targets) was issued.
- Risks flagged
- Regulatory and litigation risk (CFTC stayed a 24/7 crude filing and CME has ongoing litigation with the CFTC); competitive/market structure risk from retail-oriented perpetual futures (potential to cannibalize or create systemic risk); manipulation and susceptibility concerns in small or event-based contracts and sports/gambling-style products; monetization/timing risk for newer initiatives such as prediction markets and certain data monetization opportunities.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 22, 2026 | $2.99 est $2.91 | $1.71B est $1.68B | +7.1% |
| Apr 22, 2026 | $3.36 est $3.37 | $1.88B est $1.87B | +0.4% |
| Feb 4, 2026 | $2.77 est $2.75 | $1.65B est $1.65B | +1.5% |
| Oct 22, 2025 | $2.68 est $2.63 | $1.54B est $1.53B | +0.1% |
| Jul 23, 2025 | $2.96 est $2.91 | $1.69B est $1.69B | +0.9% |
| Apr 23, 2025 | $2.80 est $2.80 | $1.64B est $1.64B | −0.9% |
| Feb 12, 2025 | $2.52 est $2.46 | $1.53B est $1.51B | +3.5% |
| Oct 23, 2024 | $2.68 est $2.66 | $1.58B est $1.59B | +1.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
CME stock forecast and analyst price targets
Analysts’ average 12-month price target for CME is $283.60, +2.7% from the last close, from 12 firms rating the stock in the last 90 days.
$283.60consensus 12-month target, +2.7% from the last close
Now $276.01Avg $283.60
Low $230High $330
Each firm’s latest rating in the last 90 days: 12 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 3 | KBW | $285 | +3.3% |
| Sep 3 | TD Cowen | $292 | +5.8% |
| Sep 3 | UBS | $260 | −5.8% |
| Sep 3 | TD Cowen | $292 | +5.8% |
| Sep 3 | UBS | $260 | −5.8% |
+1.2%average 20-day move after past Neutral readings
+3.5%average move over the next 20 trading days in the last 5 years
±2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
CME seasonality: the next 20 trading days
Over the next 20 trading days from Sep 19, CME averaged +3.5% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.1% | 3 of 5 |
| Next 10 trading days | −0.2% | 3 of 5 |
| Next 15 trading days | +1.4% | 4 of 5 |
| Next 20 trading days | +3.5% | 4 of 5 |
| Next 30 trading days | +3.4% | 4 of 5 |
For scale, CME’s typical 20-trading-day move in either direction is about 3.5%.
CME market cap and key statistics
CME’s market cap is $99.25B, with a P/E ratio of 23.1 and revenue of $6.76B over the last twelve months.
Valuation
- Market cap
- $99.25B
- P/E ratio
- 23.1
- Forward P/E
- 22.1
- EPS, TTM
- $11.74
- Gekko Fair Value
- $273.20
Trading
- Volume
- 3.28M
- Avg volume, 20 days
- 1.85M
- 52-week high
- $329.16
- 52-week low
- $218.31
- Shares outstanding
- 359.6M
Financials
- Revenue, TTM
- $6.76B
- Profit margin
- 63.4%
- Return on equity
- 15.8%
- Quarterly earnings growth, YoY
- +2.5%
Risk and income
- Beta
- 0.28
- Typical daily move
- ±2%
- Typical 20-day move
- ±3.5%
- Dividend yield
- 1.87%
CME stock news this week
6 headlines about CME from the past week, newest first, each linking to the publisher.
- CME Group Rises 5.8% in a Year: How Should You Play the Stock?Zacks Investment Research, Sep 16
- Looking For The Ultimate Tollbooth For 24-Hour Trading: CME Group Deep DiveSeeking Alpha, Sep 16
- CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?The Motley Fool, Sep 16
- CME Group director Elizabeth Cook sells $140,055 in shares By Investing.comInvesting.com South Africa, Sep 16
- CME Group Expands Credit Ecosystem with Launch of Liquid Leveraged Loan Index FuturesPRNewsWire, Sep 15
- CME's 24/7 silver futures debut with $15 million traded in first weekendKitco, Sep 14
CME peers
CME’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| GSGoldman Sachs | Buying | 12.7% below |
| SCHWCharles Schwab | Accumulation | 7.7% below |
| IBKRInteractive Brokers | Accumulation | 6.7% below |
| HOODRobinhood Markets | Neutral | 5.4% above |
| BNYBank of New York Mellon | Accumulation | 6.5% below |
| ICEIntercontinental Exchange | Accumulation | 6.6% below |
A peer links to its own page where one exists.
CME stock FAQ
What is CME’s market cap?
CME’s market cap is $99.25B at the Sep 18, 2026 close of $276.01, with 359.6M shares outstanding. The shares trade on a P/E ratio of 23.1.
What is the CME stock forecast?
The consensus analyst 12-month price target for CME is $283.60, +2.7% from the last close. Of the 12 firms that rated the stock in the last 90 days, 4 rate it a buy, 5 a hold and 3 a sell. Gekko doesn’t publish price predictions of its own.
Is CME stock overvalued or undervalued?
On Gekko’s estimate CME is about fair value: the Sep 18, 2026 close of $276.01 is 1.0% above Gekko Fair Value of $273.20. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does CME report earnings next?
CME is expected to report on Oct 21, 2026, before the market opens (31 days away). Analysts expect earnings of $2.96 per share on revenue of $1.69B. CME beat the earnings estimate in 6 of its last 8 reports, moving 2% on average across the report.
What is CME’s 52-week high and low?
CME’s 52-week high is $329.16 and its 52-week low is $218.31; it closed at $276.01 on Sep 18, 2026, +5.2% over the past year.
Is CME stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (smart money, earnings risk and seasonality), 3 as mixed (trend, gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
How this page works
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See CME the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.